# The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance

> **NCT07514364** · PHASE4 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Mycobacterium Abscessus Lung Disease

## Interventions

- **DRUG:** Rifabutin
- **DRUG:** No Rifabutin

## Key facts

- **NCT ID:** NCT07514364
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-06-18
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514364, "The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07514364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*